Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma

This publication has 32 references indexed in Scilit:

• Prognostic Biomarker Study in Pathologically Staged N1 Non-Small Cell Lung Cancer
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Expression of proliferation associated antigens and detection of numerical chromosome aberrations in primary human liver tumours: relevance to tumour characteristics and prognosis
  Journal of Clinical Pathology, 1998
• The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma
  European Journal Of Cancer, 1997
• Ki-67 immunostaining in 322 primary breast cancers: Associations with clinical and pathological variables and prognosis
  International Journal of Cancer, 1997
• Apoptosis in human hepatocellular carcinoma and in liver cell dysplasia is correlated with p53 protein immunoreactivity.
  Journal of Clinical Pathology, 1997
• Apoptosis and proliferation of human hepatocellular carcinoma
  Liver International, 1996
• Evaluation of Ki-67 expression as a prognostic feature in hepatocellular carcinoma in cirrhosis
  European Journal Of Cancer, 1995
• Apoptosis in bladder cancer as related to standard prognostic factors and prognosis
  The Journal of Pathology, 1994
• Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma
  European Journal Of Cancer, 1994
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
  The Journal of cell biology, 1992